Article Information
- Received August 1, 2022
- Revision received May 21, 2023
- Accepted June 25, 2023
- First published July 10, 2023.
- Version of record published July 26, 2023.
Author Information
- Katharina Schregel1,2,
- Lennart Heinz1,
- Jessica Hunger1,3,
- Chenchen Pan2,4,
- Julia Bode5,
- Manuel Fischer1,
- Volker Sturm1,
- Varun Venkataramani2,4,6,
- Kianush Karimian-Jazi1,2,
- Dennis A. Agardy3,7,
- Yannik Streibel1,
- Roland Zerelles1,
- Wolfgang Wick2,4,
- Sabine Heiland1,
- Theresa Bunse3,7,
- Björn Tews5,
- Michael Platten3,7,
- Frank Winkler2,4,
- Martin Bendszus1, and
- Michael O. Breckwoldt1,3
- 1Department of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany
- 2Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
- 3Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
- 4Department of Neurology, Heidelberg University Hospital, 69120 Heidelberg, Germany
- 5Molecular Mechanisms of Tumor Invasion, Schaller Research Group at the University of Heidelberg and the German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
- 6Department of Functional Neuroanatomy, Institute for Anatomy and Cell Biology, Heidelberg University, 69120 Heidelberg, Germany
- 7Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, 68167 Mannheim, Germany
Author contributions
Author contributions: K.S. and M.O.B. designed research; K.S., J.H., C.P., J.B., M.F., V.V., K.K.-J., D.A.A., Y.S., T.B., B.T. and M.O.B. performed research; K.S., L.H., J.H., C.P., V.S., R.Z. and M.O.B. analyzed data. K.S., L.H., J.H., C.P., J.B., M.F., V.S., V.V., K.K.-J., D.A.A., Y.S., R.Z., W.W., S.H., T.B., B.T., M.P., F.W., M.B. and M.O.B. wrote the paper.
Disclosures
- Received August 1, 2022.
- Revision received May 21, 2023.
- Accepted June 25, 2023.
K.S. is supported by the Olympia-Morata program of the Medical Faculty, University of Heidelberg, and acknowledges funding from the Daimler and Benz Foundation (Grant 32-97/21). M.O.B. acknowledges funding from the Emmy Noether Program of the German Research Foundation (DFG; Grant BR 6153/1-1) and the Else Kröner-Fresenius Stiftung (Grants 2017-A25 and 2019_EKMS.23). W.W., T.B., M.P., F.W., M.B., and M.O.B. were funded by the UNITE Glioblastoma (Project-ID 404521405; Grant SFB 1389; work packages A03, B03, C02, and C03). C.P. is funded by the DFG (Grant 451894423). V.V. received financial support from the DFG (Grant VE1373/2-1), the Else Kröner-Fresenius Stiftung (Grant 2020-EKEA.135), and the University of Heidelberg (Physician Scientist-Program and Krebs und Scharlachstiftung). We thank Dr. Gergely Solecki (DKFZ Heidelberg) for help with tumor cell xenografting.
The authors declare no competing financial interests.
- Correspondence should be addressed to Michael O. Breckwoldt at michael.breckwoldt{at}med.uni-heidelberg.de or Katharina Schregel at katharina.schregel{at}med.uni-heidelberg.de
Funding
Universität Heidelberg (University of Heidelberg)
Olympia-Morata Program; Physician Scientist-Program and Krebs- und ScharlachstiftungDeutsche Forschungsgemeinschaft (DFG)
Emmy Noether Program (BR6153/1-1); SFB 1389 UNITE Glioblastoma; Project-ID 404521405; VE1373/2-1; 451894423Else Kröner-Fresenius-Stiftung (EKFS)
2017-A25; 2019_EKMS.23; 2020-EKEA.135Daimler und Benz Stiftung (Daimler and Benz Foundation)
32-97/21
Other Version
- previous version (July 10, 2023).
- You are viewing the most recent version of this article.
